Johnson & Johnson completes acquisition of Proteologix, Inc. to expand its Immunology portfolio
Acquiring Company
Johnson & Johnson
Acquired Company
Proteologix
New BrunswickRedwood Cityhospital & health careBiotechnologyHealth CareTherapeuticsDescription
Johnson & Johnson has successfully completed the acquisition of Proteologix, Inc., a biotechnology company specializing in bispecific antibodies for immune-mediated diseases. This strategic acquisition is expected to enhance Johnson & Johnson's capabilities in the development of novel therapies for a range of immune-mediated diseases.
Quick answer
Johnson & Johnson is acquiring Proteologix, announced June 21, 2024. Johnson & Johnson is based in New Brunswick, New Jersey, United States.
- How much did Johnson & Johnson pay for Proteologix?
- The deal value was not disclosed.
- What does Johnson & Johnson do?
- For over 130 years, Johnson & Johnson has maintained a tradition of quality and innovation.
- Where are Johnson & Johnson and Proteologix based?
- Johnson & Johnson is based in New Brunswick, New Jersey, United States. Proteologix is based in Redwood City, California, United States.
- Who are the decision-makers at Johnson & Johnson?
- Fundz holds 1 contact at Johnson & Johnson. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in hospital & health care and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Lantheus Holdings, Inc. acquires Meilleur Technologies, Inc. to expand Alzheimer’s diagnostic capabilities (July 15, 2024)
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- Merck completes acquisition of EyeBio to diversify its late-stage pipeline (July 12, 2024)
- Novartis BidCo Germany AG to Merge Squeeze-out MorphoSys AG’s Minority Shareholders (June 20, 2024)
- Novartis to merge with MorphoSys AG after successful acquisition and delisting agreement (June 20, 2024)
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
Who to call at Johnson & Johnson, and when
When Johnson & Johnson changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Johnson & Johnson raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Johnson & Johnson, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Johnson & Johnson. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Johnson & Johnson makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Proteologix?
Proteologix was acquired by Johnson & Johnson, based in New Brunswick. The deal was reported on June 21, 2024. For over 130 years, Johnson & Johnson has maintained a tradition of quality and innovation. Learn about the products, people and history that make up our company. Johnson & Johnson is publicly traded (JNJ) and operates in hospital & health care.
When did Johnson & Johnson acquire Proteologix?
Johnson & Johnson's acquisition of Proteologix was reported on June 21, 2024. Johnson & Johnson has successfully completed the acquisition of Proteologix, Inc., a biotechnology company specializing in bispecific antibodies for immune-mediated diseases. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Proteologix do?
Proteologix, Inc. is a privately-held biotechnology company focused on developing bispecific antibodies for immune-mediated diseases. It is privately held, operating in Biotechnology, and is based in Redwood City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.